Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 15.29% vs -17.51% in Jun 2026
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 108.04% vs -685.84% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 78.66% vs -57.61% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is -0.51% vs 6.13% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Piramal Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 15.29% vs -17.51% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 28.05% vs -8.83% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 108.04% vs -685.84% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 105.62% vs -539.22% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 78.66% vs -57.61% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 119.76% vs -53.55% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -0.51% vs 6.13% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 6.32% vs -23.43% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025